Burns - Multiple
8
0
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Reduction of Muscle Catabolism Through Brain Activation in Burn Patients
Dermacyte® Liquid for Treatment of Cutaneous Ulcers and Wounds
Effects of Chest Expansion Exercises on Thoracic Expansion and VO2 Max in Children With Chest Burn
AR Vs VR in Burns Dressing Changes
AutoMated BUrn Diagnostic System for Healthcare (AMBUSH)
Effects of a Nurse-led Transitional Burns Rehabilitation Programme
Prospective Placebo-controlled Study of Synochi Scar Spray
Local Assessment of Management of Burn Patients